In this regard, it is noteworthy that the preoperative non-invasive prediction of HCC MVI/Ki-67 dual biological markers could enhance clinicians’ understanding of patient conditions, better informing the selection of tailored treatment plans and further improving patient Survival Rates (SRs). The gene discussed is MKI67; the disease is hepatocellular carcinoma.